Physician profile
Mark J Russo
NPI 1326289786
$219,091.27
in general payments reported to CMS, 2019-2025
18 companies · $32K in 2025
The $32K reported for 2025 was more than what 95% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $40K · 2021: $29K · 2022: $11K · 2023: $26K · 2024: $25K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $25K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,388 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,740 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,000.00 |
| Travel and Lodging | $25,455.68 |
| Food and Beverage | $15,842.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,387.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,740.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $108,120.03 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Abbott Laboratories | $102,188.51 | 2019-2025 | Navitor, Mitraclip, Epic |
| Boston Scientific Corporation | $2,073.62 | 2019 | |
| Siemens Medical Solutions USA, INC. | $2,000.00 | 2019 | |
| Abiomed | $1,801.15 | 2020-2025 | Impella |
| Atricure, INC. | $934.21 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Opsens INC. | $500.00 | 2019 | |
| Dilon Technologies, INC. | $333.84 | 2023-2024 | Hemoblast Bellows |
| Medtronic, INC. | $327.34 | 2021-2025 | Corevalve Evolut R |
| Ancora Heart, INC. | $206.07 | 2024 | Accucinch |
| Jenavalve Technology, INC. | $183.17 | 2025 | |
| Medtronic Vascular, INC. | $112.28 | 2019 | |
| Shockwave Medical, INC | $90.91 | 2019 | |
| Biomerieux INC | $64.10 | 2019 | |
| Cardiva Medical, INC. | $54.03 | 2025 | Savvywire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $51.00 | 2019 | |
| Baxter Healthcare | $37.32 | 2020 | |
| Kestra Medical Technology Services, INC. | $13.69 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.